Protective Effects of N-Acetylcysteine in Concanavalin A-Induced Hepatitis in Mice

Chengfen Wang,Yujing Xia,Yuanyuan Zheng,Weiqi Dai,Fan Wang,Kan Chen,Jingjing Li,Sainan Li,Rong Zhu,Jing Yang,Qin Yin,Huawei Zhang,Junshan Wang,Jie Lu,Yingqun Zhou,Chuanyong Guo
DOI: https://doi.org/10.1155/2015/189785
2015-01-01
Mediators of Inflammation
Abstract:This study was designed to study the protective effects and mechanisms of N-acetylcysteine (NAC) in concanavalin A-induced hepatitis in mice. In this study, pretreatment with NAC ameliorated the histopathological changes and suppressed inflammatory cytokines in ConA-induced hepatitis. The expression of IL-2, IL-6, TNF-α, and IFN-γ was significantly reduced in the NAC-treated groups. NAC activated PI3K/Akt pathway and inhibited the activation of NF-κB. Additionally, NAC reduced autophagosome formation, as assessed by detecting the expression of LC3 and Beclin 1. Our results demonstrate that NAC can alleviate ConA-induced hepatitis by regulating the PI3K/Akt pathway and reducing the late stages of autophagy. Our results described a new pharmaceutical to provide more effective therapies for immune hepatitis.
What problem does this paper attempt to address?